PHK
MED icon

Point72 Hong Kong’s Medifast MED Stock Holding History

Point72 Hong Kong’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,117
Closed -$202K – 2209
2022
Q2 		$202K Buy
+1,117
New +$200K 0.01% 971
2022
Q1 		– Sell
-74
Closed -$15K – 2139
2021
Q4 		$15K Sell
74
-1,422
-95% -$294K ﹤0.01% 1587
2021
Q3 		$288K Buy
+1,496
New +$368K 0.01% 1078
2021
Q2 		– Sell
-785
Closed -$166K – 2187
2021
Q1 		$166K Buy
785
+596
+315% +$143K 0.01% 1083
2020
Q4 		$37K Buy
+189
New +$33.4K ﹤0.01% 1309
2019
Q2 		– Sell
-58
Closed -$7K – 1285
2019
Q1 		$7K Sell
58
-1,717
-97% -$218K ﹤0.01% 788
2018
Q4 		$222K Buy
1,775
+424
+31% +$72.5K 0.1% 77
2018
Q3 		$299K Buy
+1,351
New +$274K 0.1% 119

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Point72 Hong Kong's MED Position: Q3 2022 in Review

Point72 Hong Kong sold out of Medifast (MED) in Q3 2022, closing a stake of 1,117 shares — an estimated $202K sold.

Point72 Hong Kong first reported a position in MED in Q3 2018 and held it in 8 quarters. The position peaked at $299K in Q3 2018. 263 funds tracked by Wall St. Rank hold MED as of Q3 2022.

  • Point72 Hong Kong reported no remaining Medifast position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,117 Medifast shares in Q3 2022, an estimated $202K.
  • Point72 Hong Kong first reported a position in Medifast in Q3 2018 and held it in 8 quarters.
  • Point72 Hong Kong's Medifast position peaked at $299K in Q3 2018.
  • 263 funds tracked by Wall St. Rank held Medifast as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.